Proposed biosimilar accepted for review by EMA
The EMA has accepted Prestige BioPharma’s marketing application for its trastuzumab biosimilar.
List view / Grid view
The EMA has accepted Prestige BioPharma’s marketing application for its trastuzumab biosimilar.
Heritage has recalled two of its injectable treatments after microbial growths were found.
GlaxoSmithKline (GSK) has been given Chinese approval for its shingles vaccine.
Member countries of WHO have agreed to support pricing transparency for medicines, vaccines and other health products.
Global active pharmaceutical ingredients market set to surpass US$274.9 billion by 2026.
The retail prices of some anti-cancer drugs have been cut by 87 percent by the drug price control authority in India.
FDA sends warning to Petra Hygienic Systems Int LTD after they find violations of current good manufacturing practices (cGMPs).
AbbVie has announced that it has resolved its US HUMIRA (adalimumab) litigation with Boehringer Ingelheim.
As a single-source supplier of equipment solutions for the primary packaging of injectable drugs, Steriline develops, manufactures and supplies a comprehensive range of solutions, including both mechanical and robotic applications for the aseptic processing.
As a single-source supplier of equipment solutions for the primary packaging of injectable drugs, Steriline develops, manufactures and supplies a comprehensive range of solutions, including both mechanical and robotic applications for the aseptic processing.
As a single-source supplier of equipment solutions for the primary packaging of injectable drugs, Steriline develops, manufactures and supplies a comprehensive range of solutions, including both mechanical and robotic applications for the aseptic processing.
Pharmaceutical manufacturers and wholesale distributors could start losing billions of dollars because of faulty barcode scans.
Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generics industries.
14 May 2019 | By Abbott Informatics
Understand the role of data integrity in current good manufacturing practice for drugs as required in 21 CFR parts 210, 211, and 212.
Health Canada has published new guidance for manufacturers of higher-risk 3D-printed medical devices.